Immunocore is an England-based biotechnology company that develops and commercializes biological therapies for the treatment of cancer...
Read moreImmunocore is an England-based biotechnology company that develops and commercializes biological therapies for the treatment of cancer...
Read moreAnnual Revenue
$122M
Immunocore's revenue is the ranked 4th among it's top 10 competitors. The top 10 competitors average 5.4B. Over the last four quarters, Immunocore's revenue has decreased by 81.2%. Specifically, in Q4 2021's revenue was $8.5M; in Q1 2022, it was $29.6M; in Q2 2022, it was $38.9M; in Q3 2022, Immunocore's revenue was $45M.